ReviewHerz2016
Glucose-lowering therapy in type 2 diabetes. New hope after the EMPA-REG outcome trial.
G Schernthaner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewHerz2016
G Schernthaner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.